On March 25, 2025, the European Open Science Cloud (EOSC) Tripartite Governance joined in Krakow to define key developments for advancing research data and digital resource sharing across Europe.
Frederique Lisacek from SIB Swiss Institute of Bioinformatics, discusses the experimental approaches towards Glycoscience and emphasises the need for collecting and integrating glyco-related information.
The "COVID pill" by Merck, found to halve virus hospitalisation and death rates, will be sold in the US at $712 per treatment - while costing $17.74 to produce.
The study, published in The Lancet, finds that two doses of the Pfizer vaccine are 90% efficient for six months - decreasing to 47% after that time period.
New research suggests that regular walks can change brain structure - a team of scientists noticed changes in the prefrontal cortex, which improved participant concentration and memory.
According to Oxford University researchers, COVID created the largest life expectancy decrease since WWII - with 93.1% of countries seeing a significant decline.
The study, published in PLoS Biology, looked at the neurotransmitter in the brain that calculates whether to pursue a task - in other words, motivation.
In a study of nearly 60,000 people by University College London, scientists found people with depression and anxiety before COVID were a "hidden group" - extra vulnerable to long-term health and financial consequences.
South Asians have the highest rate of type 2 diabetes in the UK, due to a mix of racial and socioeconomic factors - now, researchers say that a more nuanced method of classifying race could improve their health outcomes.
New research finds that only 4% of NHS patients prefer video consultations - but 60% would be happy for Artificial Intelligence to replace official handwritten medical notes.
